BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen TT, Dung Nguyen TT, Vo TK, Tran NM, Nguyen MK, Van Vo T, Van Vo G. Nanotechnology-based drug delivery for central nervous system disorders. Biomed Pharmacother 2021;143:112117. [PMID: 34479020 DOI: 10.1016/j.biopha.2021.112117] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Tryphena KP, Singh G, Jain N, Famta P, Srivastava S, Singh SB, Khatri DK. Integration of miRNA's Theranostic Potential with Nanotechnology: Promises and Challenges for Parkinson's Disease Therapeutics. Mech Ageing Dev 2023;:111800. [PMID: 36958539 DOI: 10.1016/j.mad.2023.111800] [Reference Citation Analysis]
2 Singh J, Jindal N, Kumar V, Singh K. Role of green chemistry in synthesis and modification of graphene oxide and its application: A review study. Chemical Physics Impact 2023. [DOI: 10.1016/j.chphi.2023.100185] [Reference Citation Analysis]
3 Wei M, Yang Z, Li S, Le W. Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach. Int J Nanomedicine 2023;18:611-26. [PMID: 36760756 DOI: 10.2147/IJN.S395010] [Reference Citation Analysis]
4 Hazarika B, Singh VP. Macrocyclic supramolecular biomaterials in anti-cancer therapeutics. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108220] [Reference Citation Analysis]
5 Ahmad Malik J, Ajgaransari J, Ahmed S, Rani A, Yasmeen Ansari S, Anwar S. Emerging Selenium Nanoparticles for CNS Intervention. Biomedical Engineering 2023. [DOI: 10.5772/intechopen.109418] [Reference Citation Analysis]
6 Alkahtani S, Al-Johani NS, Alarifi S. Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects. Int J Mol Sci 2023;24. [PMID: 36674852 DOI: 10.3390/ijms24021340] [Reference Citation Analysis]
7 Conklin B, Conley BM, Hou Y, Chen M, Lee KB. Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials. Adv Drug Deliv Rev 2023;192:114636. [PMID: 36481291 DOI: 10.1016/j.addr.2022.114636] [Reference Citation Analysis]
8 Formica ML, Real DA, Picchio ML, Catlin E, Donnelly RF, Paredes AJ. On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 2022;29:101631. [DOI: 10.1016/j.apmt.2022.101631] [Reference Citation Analysis]
9 Calero M, Moleiro LH, Sayd A, Dorca Y, Miquel-rio L, Paz V, Robledo-montaña J, Enciso E, Acción F, Herráez-aguilar D, Hellweg T, Sánchez L, Bortolozzi A, Leza JC, García-bueno B, Monroy F. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.887678] [Reference Citation Analysis]
10 Díaz-García D, Ferrer-Donato Á, Méndez-Arriaga JM, Cabrera-Pinto M, Díaz-Sánchez M, Prashar S, Fernandez-Martos CM, Gómez-Ruiz S. Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone. ACS Biomater Sci Eng 2022. [PMID: 36240025 DOI: 10.1021/acsbiomaterials.2c00865] [Reference Citation Analysis]
11 Torres-vanegas JD, Cifuentes J, Puentes PR, Quezada V, Garcia-brand AJ, Cruz JC, Reyes LH. Assessing cellular internalization and endosomal escape abilities of novel BUFII-Graphene oxide nanobioconjugates. Front Chem 2022;10:974218. [DOI: 10.3389/fchem.2022.974218] [Reference Citation Analysis]
12 Barzegar Behrooz A, Talaie Z, Syahir A. Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable. Pharmaceutics 2022;14:1697. [DOI: 10.3390/pharmaceutics14081697] [Reference Citation Analysis]
13 Elfadil D, Elkhatib WF, El-Sayyad GS. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections. Microb Pathog 2022;170:105721. [PMID: 35970290 DOI: 10.1016/j.micpath.2022.105721] [Reference Citation Analysis]
14 Mohi-Ud-Din R, Mir RH, Mir PA, Banday N, Shah AJ, Sawhney G, Bhat MM, Batiha GE, Pottoo FH. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery. Curr Drug Metab 2022;23:735-56. [PMID: 35980054 DOI: 10.2174/1389200223666220817115003] [Reference Citation Analysis]
15 Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar N, Baset A, Abourehab MAS. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 2022;12:2140. [DOI: 10.3390/nano12132140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rawal SU, Patel BM, Patel MM. New Drug Delivery Systems Developed for Brain Targeting. Drugs 2022. [PMID: 35596879 DOI: 10.1007/s40265-022-01717-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Nguyen TT, Bao NS, Van Vo G. Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease. Neurochem Res 2022. [PMID: 35596041 DOI: 10.1007/s11064-022-03617-w] [Reference Citation Analysis]
18 Ahmed T, Liu FF, Lu B, Lip H, Park E, Alradwan I, Liu JF, He C, Zetrini A, Zhang T, Ghavaminejad A, Rauth AM, Henderson JT, Wu XY. Advances in Nanomedicine Design: Multidisciplinary Strategies for Unmet Medical Needs. Mol Pharm 2022. [PMID: 35587783 DOI: 10.1021/acs.molpharmaceut.2c00038] [Reference Citation Analysis]
19 Berini F, Orlandi V, Gornati R, Bernardini G, Marinelli F. Nanoantibiotics to fight multidrug resistant infections by Gram-positive bacteria: hope or reality? Biotechnol Adv 2022;:107948. [PMID: 35337933 DOI: 10.1016/j.biotechadv.2022.107948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zare I, Yaraki MT, Speranza G, Najafabadi AH, Haghighi AS, Nik AB, Manshian BB, Saraiva C, Soenen SJ, Kogan MJ, Lee JW, Apollo NV, Bernardino L, Araya E, Mayer D, Mao G, Hamblin MR. Gold nanostructures: synthesis, properties, and neurological applications. Chem Soc Rev 2022. [PMID: 35234776 DOI: 10.1039/d1cs01111a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Rakotoarisoa M, Angelov B, Drechsler M, Nicolas V, Bizien T, Gorshkova YE, Deng Y, Angelova A. Liquid crystalline lipid nanoparticles for combined delivery of curcumin, fish oil and BDNF: In vitro neuroprotective potential in a cellular model of tunicamycin-induced endoplasmic reticulum stress. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Küpeli Akkol E, Bardakcı H, Yücel Ç, Şeker Karatoprak G, Karpuz B, Khan H. A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help? Oxid Med Cell Longev 2022;2022:6168199. [PMID: 35069976 DOI: 10.1155/2022/6168199] [Reference Citation Analysis]
23 Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:748254. [PMID: 34819919 DOI: 10.3389/fendo.2021.748254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
24 Ahmad J, Haider N, Khan MA, Md S, Alhakamy NA, Ghoneim MM, Alshehri S, Sarim Imam S, Ahmad MZ, Mishra A. Novel therapeutic interventions for combating Parkinson's disease and prospects of Nose-to-Brain drug delivery. Biochem Pharmacol 2022;195:114849. [PMID: 34808125 DOI: 10.1016/j.bcp.2021.114849] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]